The Open Targets Consortium provides functional access to human genetics and genomics data to support research into drug target identification and prioritization. Researchers and institutions participating in the consortium focus esepcially on Oncology, Immunology, and Neurodegeneration. Data and research is regularly published through an openly accessible online portal.